
Mtg16/Eto2 Contributes to Murine T-Cell Development
Author(s) -
Aubrey Hunt,
Melissa A. Fischer,
Michael Engel,
Scott W. Hiebert
Publication year - 2011
Publication title -
molecular and cellular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.14
H-Index - 327
eISSN - 1067-8824
pISSN - 0270-7306
DOI - 10.1128/mcb.01458-10
Subject(s) - biology , microbiology and biotechnology
Mtg16/Eto2 is a transcriptional corepressor that is disrupted by t(16;21) in acute myeloid leukemia. Using mice lackingMtg16 , we found that Mtg16 is a critical regulator of T-cell development. Deletion ofMtg16 led to reduced thymocyte developmentin vivo , and after competitive bone marrow transplantation, there was a nearly complete failure ofMtg16 −/− cells to contribute to thymocyte development. This defect was recapitulatedin vitro asMtg16 −/− Lineage− /Sca1+ /c-Kit+ (LSK) cells of the bone marrow or DN1 cells of the thymus failed to produce CD4+ /CD8+ cells in response to a Notch signal. Complementation of these defects by reexpressingMtg16 showed that 3 highly conserved domains were somewhat dispensable for T-cell development but required the capacity of Mtg16 to suppress E2A-dependent transcriptional activation and to bind to the Notch intracellular domain. Thus, Mtg16 integrates the activities of signaling pathways and nuclear factors in the establishment of T-cell fate specification.